The course of metastatic prostate cancer under treatment
The first-line management of metastatic prostate cancer is hormonal therapy. However, resistance to this treatment will emerge within an average of 24 months. Our purpose was to determine the course of metastatic prostate cancer under treatment.
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer International Publishing
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320210/ |